Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DynamoPrEP: DMPA Impact on PrEP PK/PD
NCT03197961Phase 1Completed
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of medroxyprogesterone acetate in contraception. Primary endpoint: Tenofovir and emtricitabine levels in the female genital tract, blood, and rectum at 2 weeks. Started Nov 2017; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03197961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03197961.